Insider Trading activities at Jazz Pharmaceuticals Plc (JAZZ) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jazz Pharmaceuticals Plc (JAZZ) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jazz Pharmaceuticals Plc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1232524.

Total stock buying since 2015: $24,695,433.
Total stock sales since 2015: $175,721,274.
Total stock option exercises since 2015: $23,063,639.


 1   2   3 
33 insiders reported insider trading activities at Jazz Pharmaceuticals Plc (JAZZ):
Insider trading activities of Wilson Karen J
Insider trading activities of Berns Paul L
Insider trading activities of Larkin Finbar
Insider trading activities of Riedel Norbert G
Insider trading activities of O'keefe Kenneth W
Insider trading activities of Young Matthew P.
Insider trading activities of Oriordan Anne
Insider trading activities of Mulligan Seamus
Insider trading activities of Gala Renee D
Insider trading activities of Cozadd Bruce C
Insider trading activities of Cook Jennifer E.
Insider trading activities of Smith Mark Douglas
Insider trading activities of Carr Patricia
Insider trading activities of Pearce Samantha
Insider trading activities of Mcsharry Heather Ann
Insider trading activities of Gray Peter
Insider trading activities of Enright Patrick G
Insider trading activities of Tobias Jeffrey K
Insider trading activities of Iannone Robert
Insider trading activities of Mcgill Iain
Insider trading activities of Treacy Paul
Insider trading activities of Hooper Suzanne Sawochka
Insider trading activities of Schnee Elmar
Insider trading activities of Sohn Catherine A.
Insider trading activities of Miller Michael Patrick
Insider trading activities of Patil Neena M
Insider trading activities of Tovey Christopher J.
Insider trading activities of Sablich Kim
Insider trading activities of Smith Karen L.
Insider trading activities of Johnson Philip L
Insider trading activities of Henderson Mary Elizabeth
Insider trading activities of Cox Russell J.
Insider trading activities of Winningham Rick E

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Jazz Pharmaceuticals Plc (JAZZ).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 101,621 $10,057,861 41,509 $5,600,607 4,813 $569,040
2024 12,000 $1,435,800 17,030 $1,972,531 0 $0
2023 0 $0 48,698 $6,931,426 12,830 $966,649
2022 0 $0 178,819 $26,449,201 175,375 $10,471,706
2021 0 $0 75,994 $11,710,301 31,752 $1,486,946
2020 50,000 $5,544,330 67,130 $9,668,125 56,264 $882,841
2019 0 $0 53,277 $7,548,736 8,333 $517,809
2018 50,000 $7,179,700 87,026 $14,370,940 27,425 $2,435,236
2017 0 $0 92,629 $13,736,901 82,862 $3,685,505
2016 3,745 $477,742 125,690 $16,966,269 0 $0
2015 0 $0 359,569 $60,766,237 43,113 $2,047,907


Table 3. Detailed insider trading at Jazz Pharmaceuticals Plc (JAZZ) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-14 Treacy Paul (SVP, Technical Operations) Sale 1,304 143.35 186,932
2017-08-11 Schnee Elmar (Director) Sale 1,199 143.56 172,132
2017-08-11 Gray Peter (Director) Sale 717 143.29 102,738
2017-08-11 Mcsharry Heather Ann (Director) Sale 717 143.24 102,705
2017-08-11 Sohn Catherine A. (Director) Sale 662 143.29 94,857
2017-08-11 O'keefe Kenneth W (Director) Sale 662 143.24 94,822
2017-08-11 Winningham Rick E (Director) Sale 662 143.29 94,857
2017-08-11 Enright Patrick G (Director) Sale 662 143.25 94,828
2017-08-11 Berns Paul L (Director) Sale 662 143.25 94,828
2017-08-11 Riedel Norbert G (Director) Sale 662 143.25 94,828
2017-07-20 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,580 160.00 732,800
2017-07-17 Miller Michael Patrick (EVP, US Commercial) Sale 200 154.97 30,994
2017-06-23 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 420 160.00 67,200
2017-06-15 Miller Michael Patrick (EVP, US Commercial) Sale 200 150.65 30,130
2017-06-01 Winningham Rick E (Director) Sale 5,000 150.00 750,000
2017-05-11 Cozadd Bruce C (Chairman & CEO) Sale 30,000 153.42 4,602,660
2017-05-09 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Wilson Karen J (SVP, Finance & PAO) Sale 1,275 160.00 204,000
2017-04-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 152.56 30,512
2017-04-11 Cozadd Bruce C (Chairman & CEO) Sale 1,000 152.12 152,120
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Sale 11,458 152.24 1,744,365
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Option Ex 11,458 52.98 607,044
2017-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 137.89 27,577
2017-03-08 Wilson Karen J (SVP, Finance & PAO) Option Ex 3,646 52.98 193,165
2017-03-06 Treacy Paul (SVP, Technical Operations) Sale 884 131.97 116,665
2017-01-18 Cox Russell J. (EVP & COO) Sale 4,000 127.50 510,000
2017-01-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 115.93 23,186
2016-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 103.09 20,618
2016-12-02 Enright Patrick G (Director) Sale 1,354 101.80 137,836
2016-11-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 112.19 22,438
2016-11-14 O'keefe Kenneth W (Director) Buy 500 112.45 56,223
2016-11-11 O'keefe Kenneth W (Director) Buy 1,500 114.32 171,475
2016-10-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 118.16 23,632
2016-09-19 Miller Michael Patrick (SVP, US Commercial) Sale 200 126.17 25,234
2016-08-25 Mulligan Seamus (Director) Sale 27,968 128.19 3,585,078
2016-08-16 Treacy Paul (SVP, Technical Operations) Sale 1,292 137.46 177,603
2016-08-15 Mcsharry Heather Ann (Director) Sale 685 136.45 93,468
2016-08-15 Sohn Catherine A. (Director) Sale 633 136.45 86,372
2016-08-15 Winningham Rick E (Director) Sale 633 136.45 86,372
2016-08-15 Enright Patrick G (Director) Sale 633 136.45 86,372
2016-08-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.45 13,644
2016-08-15 Berns Paul L (Director) Sale 633 136.45 86,372
2016-08-15 Riedel Norbert G (Director) Sale 633 136.45 86,372
2016-08-12 Smith Karen L. (Global Head of R&D and CMO) Buy 608 137.18 83,406
2016-08-09 Cox Russell J. (EVP & COO) Sale 4,000 148.66 594,640
2016-08-09 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2016-07-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 142.43 14,243
2016-07-13 Smith Karen L. (Global Head of R&D and CMO) Buy 580 143.63 83,304
2016-06-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 149.64 14,963
2016-06-13 Smith Karen L. (Global Head of R&D and CMO) Buy 557 149.61 83,334
2016-05-24 Mulligan Seamus (Director) Sale 27,968 150.13 4,198,807
2016-05-16 Mcsharry Heather Ann (Director) Sale 697 145.20 101,204
2016-05-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.20 14,519
2016-05-16 Riedel Norbert G (Director) Sale 644 145.20 93,508
2016-04-25 Wilson Karen J (SVP, Finance & PAO) Sale 604 160.00 96,640
2016-04-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.79 14,579
2016-04-13 Wilson Karen J (SVP, Finance & PAO) Sale 5,007 150.00 751,050
2016-04-12 Cox Russell J. (EVP & COO) Sale 4,000 136.98 547,920
2016-04-07 Wilson Karen J (SVP, Finance & PAO) Sale 2,161 140.90 304,484
2016-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 129.17 12,916
2016-03-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 126.04 315,100
2016-02-23 Mulligan Seamus (Director) Sale 27,968 122.83 3,435,197
2016-01-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 122.66 12,266
2016-01-12 Cozadd Bruce C (Chairman & CEO) Sale 2,500 123.81 309,525
2016-01-05 Enright Patrick G (Director) Sale 10,000 138.44 1,384,379
2015-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.99 13,699
2015-12-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 139.72 349,300
2015-12-02 Enright Patrick G (Director) Sale 424 148.49 62,959
2015-12-01 Enright Patrick G (Director) Sale 10,000 146.83 1,468,300
2015-11-23 Mulligan Seamus (Director) Sale 10,243 147.65 1,512,419
2015-11-20 Mulligan Seamus (Director) Sale 17,725 145.70 2,582,567
2015-11-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 134.03 13,403
2015-11-13 Mcgill Iain (SVP, Europe & Rest of World) Sale 2,821 135.73 382,885
2015-11-10 Enright Patrick G (Director) Sale 10,000 134.48 1,344,770
2015-11-10 Cozadd Bruce C (Chairman & CEO) Sale 2,500 128.53 321,325
2015-10-21 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,000 125.00 250,006
2015-10-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 131.86 13,186
2015-10-13 Cozadd Bruce C (Chairman and CEO) Sale 2,500 131.50 328,750
2015-10-05 Enright Patrick G (Director) Sale 10,000 134.94 1,349,420
2015-09-25 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.23 14,522
2015-09-08 Cozadd Bruce C (Chairman and CEO) Sale 2,500 163.44 408,587
2015-09-01 Enright Patrick G (Director) Sale 10,000 166.36 1,663,560
2015-08-27 Enright Patrick G (Director) Sale 425 167.87 71,344
2015-08-11 Treacy Paul (SVP, Technical Operations) Sale 1,330 177.67 236,295
2015-08-11 Sohn Catherine A. (Director) Sale 654 177.77 116,258
2015-08-11 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 4,000 177.82 711,280
2015-08-11 Cox Russell J. (EVP & Chief Commercial Officer) Sale 500 177.82 88,910
2015-08-11 Cozadd Bruce C (Chairman and CEO) Sale 2,500 177.82 444,550
2015-08-10 Gray Peter (Director) Sale 867 182.02 157,812
2015-08-10 Mcsharry Heather Ann (Director) Sale 867 181.15 157,052
2015-08-10 Sohn Catherine A. (Director) Sale 801 182.02 145,798
2015-08-10 Winningham Rick E (Director) Sale 801 181.67 145,518
2015-08-10 Enright Patrick G (Director) Sale 10,801 181.97 1,965,511
2015-08-10 Berns Paul L (Director) Sale 801 181.67 145,518
2015-08-10 Riedel Norbert G (Director) Sale 801 181.67 145,517
2015-07-14 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 177.79 711,160
2015-07-14 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 4,000 46.83 187,320
2015-07-14 Cozadd Bruce C (Chairman & CEO) Sale 5,000 177.79 888,950
2015-07-06 Enright Patrick G (Director) Sale 10,000 177.25 1,772,490
2015-06-09 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 173.16 692,640
2015-06-09 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 4,000 46.83 187,320
2015-06-09 Cozadd Bruce C (Chairman & CEO) Sale 5,000 173.16 865,800
2015-06-02 Wilson Karen J (SVP, Finance & PAO) Sale 257 180.00 46,260
2015-06-01 Wilson Karen J (SVP, Finance & PAO) Sale 5,494 179.62 986,859
2015-06-01 Wilson Karen J (SVP, Finance & PAO) Option Ex 5,494 52.98 291,072
2015-06-01 Enright Patrick G (Director) Sale 10,000 178.67 1,786,690
2015-05-26 Mcgill Iain (SVP, Europe and Rest of World) Sale 7,334 179.48 1,316,328
2015-05-26 Mcgill Iain (SVP, Europe and Rest of World) Option Ex 7,334 52.98 388,555
2015-05-12 Gray Peter (Director) Sale 704 174.50 122,848
2015-05-12 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 173.85 695,400
2015-05-12 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 2,073 46.83 97,078
2015-05-12 O'keefe Kenneth W (Director) Sale 1,218 174.90 213,025
2015-05-12 O'keefe Kenneth W (Director) Option Ex 4,500 46.83 210,735
2015-05-12 Cozadd Bruce C (Chairman & CEO) Sale 5,000 173.85 869,250
2015-05-12 Riedel Norbert G (Director) Sale 650 174.47 113,408
2015-05-11 Enright Patrick G Sale 10,000 176.31 1,763,050
2015-04-14 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,000 181.45 725,800
2015-04-14 Cox Russell J. (EVP & COO) Sale 500 181.45 90,725
2015-04-14 Cozadd Bruce C (Chairman & CEO) Sale 5,000 181.45 907,250
2015-04-06 Enright Patrick G Sale 10,000 169.17 1,691,730
2015-03-25 Mulligan Seamus (Director) Sale 50,000 176.22 8,810,750
2015-03-18 Mulligan Seamus (Director) Sale 50,000 185.00 9,250,000
2015-03-10 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 1,851 170.36 315,336
2015-03-10 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 1,851 46.83 86,682
2015-03-10 Cozadd Bruce C (Chairman & CEO) Sale 5,000 170.35 851,750
2015-03-05 Cox Russell J. (EVP & COO) Sale 500 175.10 87,550
2015-03-04 Wilson Karen J (SVP, Finance & PAO) Option Ex 5,159 37.15 191,631
2015-03-03 Wilson Karen J (SVP, Finance & PAO) Sale 2,598 176.27 457,949
2015-03-02 Enright Patrick G Sale 10,000 175.60 1,755,980
2015-02-10 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 1,851 166.90 308,931
2015-02-10 Hooper Suzanne Sawochka (EVP & General Counsel) Option Ex 1,851 46.83 86,682
2015-02-10 Tobias Jeffrey K (EVP, R&D & CMO) Sale 5,000 166.91 834,545
2015-02-10 Tobias Jeffrey K (EVP, R&D & CMO) Option Ex 5,000 46.83 234,150
2015-02-10 Enright Patrick G Sale 10,000 167.37 1,673,650
2015-02-10 Cozadd Bruce C (Chairman & CEO) Sale 5,000 166.90 834,500
2015-01-13 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 1,851 161.73 299,362
2015-01-13 Hooper Suzanne Sawochka (EVP and General Counsel) Option Ex 1,851 46.83 86,682
2015-01-13 Cozadd Bruce C (Chairman and CEO) Sale 5,000 161.73 808,650
2015-01-05 Enright Patrick G Sale 10,000 160.66 1,606,600
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of JAZZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jazz Pharmaceuticals Plc (symbol JAZZ, CIK number 1232524) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.